In the FDA’s latest From a Global Perspective, Marta Sokolowska from the FDA and Steffen Thirstrup from the European Medicines Agency (EMA) provide their “Regulatory Perspectives on Herbal Medicinal / Botanical Drug Development.” This conversation between leaders of each agency focused on the recent FDA/EMA workshop on this topic and how the regulators are working together to support herbal medicinal and botanical drug product development.